CTSI Update
An Interactive Seminar Series for Postdoctoral Fellows
and Early Career Faculty (formerly the CREST Program)
Want to learn how to write an effective abstract and paper? Get familiar with qualitative methods? Give a professional talk? How to position yourself to write a career development award? Ways to use social media to promote your research activities? Then this Seminar Series is for you. Read More

The CTSI is offering a 2-year curriculum to help fellows and early career faculty members acquire skills to advance their research careers.  
New Funding Opportunities

Due: August 31, 2020
Funding: $50,000–150,000
Purpose: To support research intended to advance the medical knowledge of migraine in the following areas of interest:
  • Non-interventional clinical research with a focus on early diagnosis and treatment, epidemiology, and Patient Reported Outcomes 
  • Biomarkers for diagnosis and prognosis.
  • Preclinical research focused on mechanism of disease 

Due: August 31, 2020
Funding: $50,000
Project period: One year
Purpose: This award is intended to stimulate the entry of early-career scientists into areas of research related to eczema, as they seek to become an independent research investigator with a commitment to this field.

Due: September 29, 2020 (LOI).
Purpose: To address important decisional dilemmas that require important new evidence about the comparative effectiveness of available interventions. 

Visualization Methods and Tools Development for Enhancing Cancer Moonshot Data (R33 Clinical Trial Not Allowed)

National Cancer Institute (NCI)

Grants for HIV Research (P01 Clinical Trial Optional)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Notice of Special Interest: Alcohol and Aging

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Administrative Supplements to Support Emerging Physician-Scientists to Develop Research Expertise in Diabetes, Endocrinology and Metabolic Diseases

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
News Highlights
The Virus vs the Machine
Several groups of IRP researchers are examining our genes and their behavior for clues as to why some COVID-19 patients experience more severe symptoms than others.
Experimental Compound Clocks SARS-CoV-2’s Ability to Infect and Kill Cells in the Lab
 In laboratory experiments, the compound inhibits the virus’ ability to infect and destroy cells, suggesting that with further development and testing, it might be an effective treatment for people with the disease. 
A New Map Catalogs the Effects of Coronavirus Mutations
This new study focused on mutations to a key part of SARS-CoV-2 – its “spike protein.” This protein binds to a protein on human cells called ACE2, a necessary step for infection.
The World After Coronavirus
"Synthetic biology will much better prepare us for the next pandemic" James J. Collins, Termeer Professor of Medical Engineering and Science at MIT.
Coronavirus and the Future of Infectious Disease
How should we adapt in our daily lives to new Covid realities? What is science 'really' saying?
Check the SMART IRB’s Learning Center, It provides informational videos and resources to help investigators and study teams plan for and implement single IRB review arrangements
The Body's adaptative Immune system can learn to recognize new invading pathogenes, such as the Coronavirus SARS- CoV-2. Learn about the

Would you like to learn how how Biomedical Researchers are using generalist repositories for DataSharing?
Upcoming Event
Teaching Translational Science: Examples from the Field of Dissemination and Implementation - Thursday, September 17, 2020, 1:00 - 2:00 p.m. ET
In this one-hour webinar, Rachel C. Shelton, ScD, MPH and Aaron L. Leppin, MD, MS will reflect on their experiences teaching dissemination and implementation science to diverse groups. 
Boston University Clinical & Translational Science Institute
Accelerating Discoveries Towards Better Health 
bu.edu/ctsi | ncats.nih.gov